Nasdaq-listed Prenetics to halt Bitcoin purchases

Nasdaq-listed global healthcare company Prenetics has announced it will discontinue its Bitcoin purchasing program. According to Crypto Briefing, the company is halting the program to focus on its consumer health brand, IM8. Prenetics plans to hold its existing 510 BTC, valued at $45 million, and does not intend to sell its current holdings. The company had been consistently buying Bitcoin since announcing in June that it would strengthen its BTC treasury strategy.